Stephanie Johnson | Principal Process Development Scientist

1 min read 23rd Mar 2026

Share via email Share via LinkedIn

Stephanie Johnson PhD, MSc, BSc

Principal Process Development Scientist

Stephanie Johnson joined our dedicated bioconjugation site in Deeside, Wales in 2011 after graduating with a PhD from Bangor University. In her current role as Principal Process Development Scientist, Steph is responsible for supporting the process development of GMP projects at the site.

Education

Bangor University, 2011, PhD, Chemistry
Newcastle University, 2007, MSc, Drug Chemistry
University of York, 2006, BSc, Chemistry

Sterling Resources

Top 5 considerations in ADC process development March 2026
Phase I ADC development and manufacturing: A case study December 2022

Hex

Share via email Share via LinkedIn

Popular articles

7 min read

When ADC meets DMA: Uncovering unexpected critical parameters Read more

Building quality by design: How CPP and PAR studies ensure safe and scalable API manufacturing

Whitepaper5 min read

Building quality by design: How CPP and PAR studies ensure safe and scalable API manufacturing Read more

Whitepaper7 min read

Scaling ring-closing metathesis in API development: Challenges and success factors Read more

ADC manufacturing facilities at Sterling Pharma Solutions' Deeside, Wales facilities

Blog7 min read

Top 5 considerations in ADC clinical manufacturing Read more

One pager5 min read

HPAPI development and manufacture: From medicinal chemistry to process chemistry Read more

Scott Bruce - Head of Production

Spotlight5 min read

Scientist Snapshot | Scott Bruce, Head of Production Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

Facebook

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229